Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Alchemist The Alchemist - January 2009
Document Actions

The Alchemist - January 2009

by chemweb last modified 03-20-09 08:08 AM
The Alchemist - January 2009
The Alchemist Newsletter Logo
Not a subscriber? Join now.

January 27, 2009
 

issue overview
analytical: Removing Raman's blinkers
pharma: Anticancer dose
physical: Crystal unclear
environment: Clean air life extension
organic health: Melamine milk
grants and awards: Climatic award

 

 


This week, The Alchemist discovers how to improve analytical chemistry by keeping things cool, how to improve anticancer therapy by lowering the dose and increasing frequency, and how to reduce lime scale in hot water appliances. Also this week a fall in air pollution has improved the life expectancy of Americans, melamine sentences have been passed in China, and pioneering global warming research earns geochemist Wallace Broecker one of the biggest cash prizes in science.

back to top

 


Removing Raman’s blinkers

An international research team has circumvented the “signal-blinking” problem seen when probing a single molecule using surface-enhanced Raman scattering (SM-SERS). Jiannian Yao of the Chinese Academy of Sciences working with researchers in Sweden, has combined theory and experiment to demonstrate how cooling a molecule can eradicate the blinking that otherwise distorts the Raman picture. "It sounds straightforward," says Yao, "but this needs special consideration of the experimental set up." The team demonstrated proof of principle using the non-bonding molecule, perylene, which was physically adsorbed on colloidal silver nanoparticles.

Single molecules cooling off

back to top

 


Anticancer dose

The mode of action of a whole class of anticancer drugs has been revealed by Johns Hopkins scientists. Gregg Semenza and colleagues have vindicated the high-frequency low-dose regime for anthracyclines proposed by Judah Folkman in 2000 and known as the metronomic treatment. The class includes the common anticancer agents doxorubicin, daunorubicin, epirubicin, and idarubicin, which have been used since the 1960s for treating leukemia, lymphoma, sarcomas, and carcinomas.

Semenza and colleagues investigated whether or not these drugs and inhibit the gene-activating ability of hypoxia-inducible factor, or HIF-1, which triggers blood vessel growth, angiogenesis. The team examined tumors from drug-treated mice and found that the number of blood vessels was dramatically reduced compared to controls. Additional tests revealed that the genes that HIF-1 turns on to drive blood vessel formation were turned off in tumors from the drug-treated mice.

How chemotherapy drugs block blood vessel growth, slow cancer spread

back to top

 


Crystal unclear

Conventional wisdom cannot explain the intricacies of that apparently mundane material, calcium carbonate. Researchers at the Max Planck Institute of Colloids and Interfaces, in Golm near Potsdam, Germany, investigated the crystallization of calcium carbonate. They found that it forms stable nanoclusters, of a few dozen calcium and carbonate ions, in water even at low concentration, which is not how things are supposed to happen, according to the crystallization theory.

At higher concentrations, a precipitate forms. "It seems that it is already decided when the clusters form, which of the three anhydrous crystal structures calcium carbonate will assume," says team leader Helmut Coelfen. "We also observed that the crystal structure depends on the pH level." At pH just above neutral, calcite forms, but at high pH, vaterite, a non-stable crystalline structure emerges. The work has implications for reducing lime scale in domestic hot water appliances, industrial boilers, and even atmospheric and ocean carbon dioxide levels.

A crystal clear view of chalk formation

back to top

 


Clean air life extension

Improvements in urban air quality across 51 cities in the US could be responsible for an average increase in lifespan of 21 weeks, and may have added almost three years for some people, according to epidemiologist Arden Pope, and colleagues at Brigham Young University, Utah. Changes in tobacco smoking habits are the biggest factor to have increased American life expectancy followed by improved socioeconomic conditions, but air quality is a major factor too, Pope and his colleagues found. "It's stunning that the air pollution effect seems to be as robust as it is after controlling for these other things," Pope said.

Cleaner air equals 21 more weeks of life

back to top

 


Melamine milk

The scandal surrounding the illicit use of melamine in infant formula milk in China has come to a head this week. Hundreds of thousands of infants were poisoned by the formula milk, which was deliberately contaminated with the high-nitrogen compound melamine to spoof protein levels. At least six infants died. Compensation has now been offered to some families affected and the protagonists at the center of the controversy have been sentenced. Death sentences were served on two individuals, cattle farmer Zhang Yujun and milk trader Geng Jinping. The former boss at Sanlu, the manufacturer involved in the scandal, has been given a life sentence and a fine of almost $3 million.

Chinese milk scam duo face death

back to top

 


Climatic award

Geochemist Wallace Broecker at Columbia University's Lamont-Doherty Earth Observatory has received the recently inaugurated Frontiers of Knowledge Award in Climate Change Research. At just over half a million dollars the prize is one of the biggest in science. Broecker sounded early alarms on climate change and carried out pioneering work into the interaction between the oceans and the atmosphere. One of the first mentions of the term "global warming" appeared in a paper by Broecker in the journal Science in 1975.

Wallace Broecker Wins (Yet Another) Top Prize

back to top

 

-- David Bradley, Science Journalist

 

 
SPONSORED BY

FREE Magazines

Trade Publications FREE to Qualified subscribers of "The Alchemist" and Chemweb.com. No hidden or trial offers, and no purchase necessary. Publications are absolutely free to those who qualify.

Sign-up here


Free Newsletters

ChemIndustry.com's Newsletter Center invites you to subscribe to newsletters of your interest - free of charge.

Click here for details

Previous Issues

Jan 13, 2009
Dec 24, 2008
Dec 10, 2008
Nov 25, 2008
Nov 13, 2008
Oct 28, 2008
Oct 14, 2008
Sep 25, 2008
Sep 10, 2008
Aug 26, 2008
Aug 12, 2008
Jul 23, 2008
Jul 09, 2008
Jun 24, 2008
Jun 11, 2008
May 28, 2008
May 14, 2008
Apr 24, 2008
Apr 9, 2008
Mar 25, 2008
Mar 12, 2008
Feb 27, 2008
Feb 13, 2008
Jan 22, 2008
Jan 08, 2008
Dec 12, 2007
Nov 27, 2007
Nov 14, 2007
Oct 24, 2007
Oct 10, 2007
Sep 26, 2007
Sep 11, 2007
Aug 30, 2007
Aug 15, 2007
Jul 25, 2007
Jul 11, 2007
Jun 27, 2007
Jun 13, 2007
May 24, 2007
May 8, 2007
Apr 23, 2007
Apr 10, 2007
Mar 27, 2007
Mar 13, 2007
Feb 27, 2007
Feb 13, 2007
Jan 23, 2007
Jan 9, 2007
Dec 12, 2006
Nov 28, 2006
Nov 14, 2006
Oct 24, 2006
Oct 10, 2006
Sep 26, 2006
Sep 12, 2006
Aug 22, 2006
Aug 9, 2006
Jul 25, 2006
Jul 11, 2006
Jun 27, 2006
Jun 13, 2006
May 23, 2006
May 9, 2006
Apr 25, 2006
Apr 11, 2006
Mar 14, 2006
Feb 28, 2006
Feb 14, 2006
Jan 24, 2006
Jan 10, 2006
Dec 20, 2005
Dec 6, 2005
Nov 15, 2005
Nov 1, 2005
Oct 18, 2005
Oct 4, 2005
Sep 20, 2005
Sep 6, 2005
Aug 18, 2005
Aug 2, 2005
July 19, 2005
July 08, 2005
June 21, 2005
June 7, 2005
May 17, 2005
May 3, 2005
Apr 18, 2005
Apr 8, 2005
Mar 22, 2005
Mar 8, 2005
Feb 22, 2005
Feb 8, 2005
Jan 25, 2005
Jan 11, 2004
Dec 28, 2004
Dec 14, 2004
Nov 30, 2004
Nov 11, 2004
Oct 29, 2004
Oct 13, 2004
Sep 28, 2004
Sep 13, 2004
Aug 19, 2004

 
   

The Alchemist is published under the copyright of ChemIndustry.com Inc.©2008. For additional information including contact information and sponsorship opportunities, please contact Rick Whiteman <Rick@ChemWeb.com> or visit our web sites at www.chemweb.com and www.chemindustry.com.

Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: